Samjin Pharma Major Shareholder Choe Seung-ju Reports Changes in Pledge Contracts, No Change in Stake or Voting Rights (Neutral)
The report by Choe Seung-ju and 12 special relations shows unchanged aggregate holding of 1,375,889 shares (10.33%) in Samjin Pharmaceutical.
Filing reason is 'change in major contract details': 7 stock pledge loan contracts involving special relations were amended (mainly extension of existing terms).
Total pledged shares: 559,624 (4.20%); total loan amount approx. 6.75 billion KRW, small relative to market cap.
Maintenance margin ratio of 140% is typical; risk of margin call is low, limiting potential forced selling.
The filer states holding with intent to influence management, aiming to maximize shareholder value in key decisions.
[AI Summary]This disclosure merely reflects changes in the terms of stock pledge loans by the Choe family. No change in ownership or voting rights, hence neutral for shareholder value. The pledge amount is small relative to market cap and the collateral ratio is stable, implying low dilution or forced selling risk.